| --- | --- | --- | --- | --- | --- | |----------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | NASDAQ: MRVI | | | | | | | Investor | | | | | | | Presentation | | | | | | | March 15, 2023 | | | | | | ©2023 Maravai LifeSciences. This document and its contents are confidential and proprietary and are not to be shared or redistributed without express consent. Forward looking statements and use of non-GAAP financial measures This presentation contains, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39725 Maravai LifeSciences Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 85-2786970 (State or other jurisdiction of incorporation (I.R.S. Employe ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2022 Earnings Conference Call February 22, 2023 5:00 PM ET Company Participants Debra Hart - Head of Investor Relations Carl Hull - Interim Chief Executive Officer Kevin Herde - Chief Financial Officer Trey Martin - President of Biologic Safety Testing Becky Buzzeo - Chief Commercial Officer Conference Call Participants Dan Leonard - Credit Suisse Matthew Sykes - Goldman Sachs Daniel Arias - Stifel Catherine Schulte - Robert W. Baird Tejas Savant - Mor ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2022 Results Conference Call November 2, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Interim Chief Executive Officer Kevin Herde - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley John Sourbeer - UBS Paul Knight - KeyBanc Madeline Mollman - William Blair Michael Ryskin - Bank of America Dan Arias - Stifel Dan Leonard - Credit Suisse Brandon Couillard - Jefferies Operator Greeting ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Officer Kevin Herde - Chief Financial Officer Conference Call Participants Max Smock - William Blair & Company Matthew Sykes - Goldman Sachs Tejas Savant - Morgan Stanley Paul Knight - KeyBanc Capital Markets Inc. Michael Ryskin - Bank of America Brandon Couillard - Jefferies Group LLC John Sourbeer - UBS Group AG ...

Q2 2022 Financial Results (Nasdaq: MRVI) August 4, 2022 eSciences Today's Agenda Welcome Deb Hart, Head of Investor Relations 01 Financial Results & Guidance Kevin Herde, Chief Financial Officer 02 Business Highlights & Update Carl Hull, Chief Executive Officer 03 04 Q&A Session Carl Hull, Chief Executive Officer Kevin Herde, Chief Financial Officer 2 Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains, and our officers and representatives may from time-to-time make, ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Officer Kevin Herde - Executive Vice President and Chief Financial Officer Conference Call Participants Paul Knight - KeyBanc Capital Markets Operator Good day and thank you for standing by. Welcome to Maravai LifeSciences First Quarter 2022 Earnings Conference Call. Please be advised that today's conference is being ...

Q1 2022 Financial Results (Nasdaq: MRVI) May 5, 2022 LifeSciences Today's Agenda Welcome Deb Hart, Head of Investor Relations 01 Financial Results & Guidance Kevin Herde, Chief Financial Officer 02 Business Highlights & Update Carl Hull, Chief Executive Officer 03 04 Q&A Session Carl Hull, Chief Executive Officer Kevin Herde, Chief Financial Officer 2 Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains, and our officers and representatives may from time-to-time make, ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Officer Kevin Herde - Executive Vice President and Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Yuko Oku - Morgan Stanley Paul Knight - KeyBanc Capital Markets Matt Larew - William Blair Catherine Schulte - Baird Michael Ryskin - Bank of America Merrill Lynch John Sourbeer - ...

Q4 2021 Financial Results (Nasdaq: MRVI) February 23, 2022 LifeSciences Today's Agenda Welcome Deb Hart, Head of Investor Relations 01 Financial Results & Guidance Kevin Herde, Chief Financial Officer 02 Business Highlights & Update Carl Hull, Chief Executive Officer 03 04 Q&A Session Carl Hull, Chief Executive Officer Kevin Herde, Chief Financial Officer 2 Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains, and our officers and representatives may from time-to-time ...